THEMIS is Required for Pathogenesis of Cerebral Malaria and for Protection against Pulmonary Tuberculosis
*Department of Human Genetics, McGill University, Montreal, QC, Canada; †Complex Traits Group, McGill University, Montreal, QC, Canada; ‡Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada; §Department of Biochemistry, McGill University, Montreal, QC, Canada; ¶McGill and Genome Quebec Innovation Center, McGill University, Montreal, QC, Canada; ||Trudeau Institute Inc., Saranac Lake, New York, United States of America.
We identify an N-ethyl-N-nitrosourea (ENU)-induced I23N mutation in the THEMIS protein that causes protection against experimental cerebral malaria (ECM) caused by infection with Plasmodium berghei ANKA (PbA). ThemisI23N homozygote mice show reduced CD4+ and CD8+ T lymphocyte numbers. ECM-resistance in PbA-infected ThemisI23N mice is associated with decreased cerebral cellular infiltration, retention of blood-brain barrier integrity, and reduced pro-inflammatory cytokine production. THEMISI23N protein expression is absent in mutant mice, concurrent with decreased THEMISI23N stability observed in vitro. Biochemical studies in vitro, and functional complementation in vivo in ThemisI23N/+:Lck-/+ double-heterozygotes demonstrate that functional coupling of THEMIS to LCK tyrosine kinase is required for ECM pathogenesis. Dampening of pro-inflammatory responses in ThemisI23N mice causes susceptibility to pulmonary tuberculosis. Thus, THEMIS is required for development, and ultimately function of pro-inflammatory T cells. ThemisI23N mice can be used to study the newly discovered association of THEMIS (6p22.33) with inflammatory bowel disease, and multiple sclerosis.
Keywords: cerebral malaria, T-cells, neuroinflammation